메뉴 건너뛰기




Volumn 57, Issue 10, 2007, Pages 665-678

Prospective controlled cohort studies on long-term therapy of ovarian cancer patients with mistletoe (Viscum album L.) extracts Iscador

Author keywords

Alternative medicine; Complementary medicine; Iscador ; Mistletoe extracts Iscador; Ovarian cancer, overall survival, quality of life; Viscum album L.

Indexed keywords

VISCUM ALBUM EXTRACT;

EID: 35948942274     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1296666     Document Type: Article
Times cited : (42)

References (49)
  • 1
    • 1642579678 scopus 로고    scopus 로고
    • Complementary and alternative therapies for cancer
    • February 1
    • Cassileth BR, Deng G. Complementary and alternative therapies for cancer. Oncologist. 2004(February 1);9(1):80-89.
    • (2004) Oncologist , vol.9 , Issue.1 , pp. 80-89
    • Cassileth, B.R.1    Deng, G.2
  • 3
    • 34147101252 scopus 로고    scopus 로고
    • Complementary cancer therapy: A systematic review of prospective clinical trials on anthroposophic mistletoe extracts
    • Kienle GS, Kiene H. Complementary cancer therapy: a systematic review of prospective clinical trials on anthroposophic mistletoe extracts. Eur J Med Res. 2007;12:1-17.
    • (2007) Eur J Med Res , vol.12 , pp. 1-17
    • Kienle, G.S.1    Kiene, H.2
  • 4
    • 0141449180 scopus 로고
    • Über die Zusatzbehandlung beim weiblichen Genitalkarzinom
    • Majewski A, Bentele W. Über die Zusatzbehandlung beim weiblichen Genitalkarzinom. Zentralbl Gynäkol. 1963;85 (20):696-700.
    • (1963) Zentralbl Gynäkol , vol.85 , Issue.20 , pp. 696-700
    • Majewski, A.1    Bentele, W.2
  • 5
    • 0035004688 scopus 로고    scopus 로고
    • Use of Iscador, an extract of European mistletoe (Viscum album), in cancer treatment: Prospective nonrandomized and randomized matched-pairs studies nested within a cohort study
    • Grossarth-Maticek R, Kiene H, Baumgartner S, Ziegler R. Use of Iscador, an extract of European mistletoe (Viscum album), in cancer treatment: prospective nonrandomized and randomized matched-pairs studies nested within a cohort study. Altern Ther Health Med. 2001;7(3):57-78.
    • (2001) Altern Ther Health Med , vol.7 , Issue.3 , pp. 57-78
    • Grossarth-Maticek, R.1    Kiene, H.2    Baumgartner, S.3    Ziegler, R.4
  • 6
    • 33750388867 scopus 로고    scopus 로고
    • Prospective controlled cohort studies on long-term therapy of breast cancer patients with a mistletoe preparation (Iscador)
    • Grossarth-Maticek R, Ziegler R. Prospective controlled cohort studies on long-term therapy of breast cancer patients with a mistletoe preparation (Iscador). Forsch Komplementärmed. 2006;13:285-292.
    • (2006) Forsch Komplementärmed , vol.13 , pp. 285-292
    • Grossarth-Maticek, R.1    Ziegler, R.2
  • 7
    • 33747242669 scopus 로고    scopus 로고
    • Circular instead of hierarchical: Methodological principles for the evaluation of complex interventions
    • Walach H, Falkenberg T, Fonnebo V, Lewith G, Jonas WB. Circular instead of hierarchical: methodological principles for the evaluation of complex interventions. BMC Med Res Methodol. 2006;6(29).
    • (2006) BMC Med Res Methodol , vol.6 , Issue.29
    • Walach, H.1    Falkenberg, T.2    Fonnebo, V.3    Lewith, G.4    Jonas, W.B.5
  • 8
    • 33845518673 scopus 로고    scopus 로고
    • Randomised and non-randomised prospective controlled cohort studies in matched pair design for the long-term therapy of breast cancer patients with a mistletoe preparation (Iscador): A re-analysis
    • Grossarth-Maticek R, Ziegler R. Randomised and non-randomised prospective controlled cohort studies in matched pair design for the long-term therapy of breast cancer patients with a mistletoe preparation (Iscador): A re-analysis. Europ J Med Res. 2006;11(11):485-495.
    • (2006) Europ J Med Res , vol.11 , Issue.11 , pp. 485-495
    • Grossarth-Maticek, R.1    Ziegler, R.2
  • 12
    • 0000733019 scopus 로고
    • Self-regulation and mortality from cancer, coronary heart disease, and other causes: A prospective study
    • Grossarth-Maticek R, Eysenck HJ. Self-regulation and mortality from cancer, coronary heart disease, and other causes: a prospective study. Pers Individ Diff. 1995;19(6):781-795.
    • (1995) Pers Individ Diff , vol.19 , Issue.6 , pp. 781-795
    • Grossarth-Maticek, R.1    Eysenck, H.J.2
  • 14
    • 0033970588 scopus 로고    scopus 로고
    • Interaction of psychosocial and physical risk factors in the causation of mammary cancer, and its prevention through psychological methods of treatment
    • Grossarth-Maticek R, Eysenck H-J, Boyle GJ, Heeb J, Costa SD, Diel IJ. Interaction of psychosocial and physical risk factors in the causation of mammary cancer, and its prevention through psychological methods of treatment. J Clin Psych. 2000;56(1):33-50.
    • (2000) J Clin Psych , vol.56 , Issue.1 , pp. 33-50
    • Grossarth-Maticek, R.1    Eysenck, H.-J.2    Boyle, G.J.3    Heeb, J.4    Costa, S.D.5    Diel, I.J.6
  • 16
    • 0029067082 scopus 로고
    • Method of test administration as a factor in text validity: The use of a personality questionnnaire in the prediction of cancer and coronary heart disease
    • Grossarth-Maticek R, Eysenck HJ, Boyle GJ. Method of test administration as a factor in text validity: the use of a personality questionnnaire in the prediction of cancer and coronary heart disease. Behav Res Ther. 1995;33(6):705-710.
    • (1995) Behav Res Ther , vol.33 , Issue.6 , pp. 705-710
    • Grossarth-Maticek, R.1    Eysenck, H.J.2    Boyle, G.J.3
  • 18
    • 0001586397 scopus 로고    scopus 로고
    • Biological and pharmacological properties of Viscum album L
    • Büssing A, ed, Amsterdam: Harwood Academic Publisher;
    • Bussing A. Biological and pharmacological properties of Viscum album L. In: Büssing A, ed. Mistletoe: The Genus Viscum. Amsterdam: Harwood Academic Publisher; 2000. p. 123-182.
    • (2000) Mistletoe: The Genus Viscum , pp. 123-182
    • Bussing, A.1
  • 19
    • 3442902177 scopus 로고    scopus 로고
    • Mistel (Viscum album) - anthroposophischer und phytotherapeutischer Ansatz
    • Münstedt K, ed, Landsberg: Ecomed;
    • Bussing A. Mistel (Viscum album) - anthroposophischer und phytotherapeutischer Ansatz. In: Münstedt K, ed. Ratgeber Unkonventionelle Methoden. Landsberg: Ecomed; 2003. p. 184-199.
    • (2003) Ratgeber Unkonventionelle Methoden , pp. 184-199
    • Bussing, A.1
  • 20
  • 21
    • 35948964963 scopus 로고    scopus 로고
    • Büssing A. Pharmakologische Wirkungen von Mistelextrakten. In: Fintelmann V, ed. Onkologie auf anthroposophischer Grundlage. Stuttgart: Mayer (1. Lieferung); 2002. Section 3.2.4.1.
    • Büssing A. Pharmakologische Wirkungen von Mistelextrakten. In: Fintelmann V, ed. Onkologie auf anthroposophischer Grundlage. Stuttgart: Mayer (1. Lieferung); 2002. Section 3.2.4.1.
  • 22
    • 33748663282 scopus 로고    scopus 로고
    • Immune modulation using mistletoe (Viscum album L.) extracts Iscador
    • Büssing A. Immune modulation using mistletoe (Viscum album L.) extracts Iscador. Arzneimittel-Forschung (Drug Research). 2006;56(6a):508-515.
    • (2006) Arzneimittel-Forschung (Drug Research) , vol.56 , Issue.6 A , pp. 508-515
    • Büssing, A.1
  • 23
    • 33748641369 scopus 로고    scopus 로고
    • Absence of tumor growth stimulation in a panel of 26 human tumor cell lines by mistletoe (Viscum album L.) extracts Iscador
    • Kelter G, Fiebig HH. Absence of tumor growth stimulation in a panel of 26 human tumor cell lines by mistletoe (Viscum album L.) extracts Iscador. Arzneimittel-Forschung (Drug Research). 2006;56(6a):435-440.
    • (2006) Arzneimittel-Forschung (Drug Research) , vol.56 , Issue.6 A , pp. 435-440
    • Kelter, G.1    Fiebig, H.H.2
  • 24
    • 33748665010 scopus 로고    scopus 로고
    • Preclinical investigations with mistletoe (Viscum album L.) extracts Iscador
    • Maldacker J. Preclinical investigations with mistletoe (Viscum album L.) extracts Iscador. Arzneimittel-Forschung (Drug Research). 2006;56(64):497-507.
    • (2006) Arzneimittel-Forschung (Drug Research) , vol.56 , Issue.64 , pp. 497-507
    • Maldacker, J.1
  • 26
    • 0035906308 scopus 로고    scopus 로고
    • The CONSORT Statement: Revised recommendations for improving the quality of reports of parallel-group randomized trials
    • Moher D, Schulz KF, Altman DG. The CONSORT Statement: Revised recommendations for improving the quality of reports of parallel-group randomized trials. J Am Med Assoc. 2001;285:1987-1991.
    • (2001) J Am Med Assoc , vol.285 , pp. 1987-1991
    • Moher, D.1    Schulz, K.F.2    Altman, D.G.3
  • 27
    • 4644367501 scopus 로고    scopus 로고
    • Guidelines for reporting non-randomised studies
    • Reeves BC, Gaus W. Guidelines for reporting non-randomised studies. Forsch Komplementärmed. 2004;11 (Suppl 1):46-52.
    • (2004) Forsch Komplementärmed , vol.11 , Issue.SUPPL. 1 , pp. 46-52
    • Reeves, B.C.1    Gaus, W.2
  • 34
    • 0000958776 scopus 로고    scopus 로고
    • Ovarian Cancer, Fallopian Tube Carcinoma, and Peritoneal Carcinoma
    • DeVita Jr VT, Hellman S, Rosenberg SA, eds, 6th ed. Philadelphia: Lippincott Williams & Wilkins;
    • Ozols RF, Schwartz PE, Eifel PJ. Ovarian Cancer, Fallopian Tube Carcinoma, and Peritoneal Carcinoma. In: DeVita Jr VT, Hellman S, Rosenberg SA, eds. Cancer: Principles & Practice of Oncology (Section 365). 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2001. p. 1597-1632.
    • (2001) Cancer: Principles & Practice of Oncology (Section 365) , pp. 1597-1632
    • Ozols, R.F.1    Schwartz, P.E.2    Eifel, P.J.3
  • 35
    • 4644347319 scopus 로고    scopus 로고
    • Reasons for caution when evaluating health care interventions using non-randomised study designs
    • Reeves BC. Reasons for caution when evaluating health care interventions using non-randomised study designs. Forsch Komplementärmed. 2004;11(Suppl 1):40-45.
    • (2004) Forsch Komplementärmed , vol.11 , Issue.SUPPL. 1 , pp. 40-45
    • Reeves, B.C.1
  • 36
    • 1442350530 scopus 로고    scopus 로고
    • Impact of complementary mistletoe extract treatment on quality of life in breast, ovarian and non-small cell lung cancer patients. A prospective randomized controlled clinical trial
    • Piao BK, Wang YX, xie GR, Mansmann U, Matthes H, Beuth J, et al. Impact of complementary mistletoe extract treatment on quality of life in breast, ovarian and non-small cell lung cancer patients. A prospective randomized controlled clinical trial. Anticancer Res. 2004;24(1):303-310.
    • (2004) Anticancer Res , vol.24 , Issue.1 , pp. 303-310
    • Piao, B.K.1    Wang, Y.X.2    xie, G.R.3    Mansmann, U.4    Matthes, H.5    Beuth, J.6
  • 38
    • 0028191359 scopus 로고
    • Mistletoe treatment for cancer: Review of controlled trials in humans
    • Kleijnen J, Knipschild P. Mistletoe treatment for cancer: review of controlled trials in humans. Phytomedicine. 1994;1:255-260.
    • (1994) Phytomedicine , vol.1 , pp. 255-260
    • Kleijnen, J.1    Knipschild, P.2
  • 39
    • 0018741234 scopus 로고
    • Welche Erfolgsaussichten bietet die Iscador-Therapie beim fortgeschrittenen Ovarialkarzinom?
    • Hassauer W, Gutsch J, Burkhardt R. Welche Erfolgsaussichten bietet die Iscador-Therapie beim fortgeschrittenen Ovarialkarzinom? Onkologie. 1979;2(1):28-36.
    • (1979) Onkologie , vol.2 , Issue.1 , pp. 28-36
    • Hassauer, W.1    Gutsch, J.2    Burkhardt, R.3
  • 40
    • 0020326045 scopus 로고
    • Die Iscadortherapie beim Ovarialkarzinom
    • Leroi R, Hajto T. Die Iscadortherapie beim Ovarialkarzinom. Krebsgeschehen. 1982;14(2):38-44.
    • (1982) Krebsgeschehen , vol.14 , Issue.2 , pp. 38-44
    • Leroi, R.1    Hajto, T.2
  • 41
    • 35948959136 scopus 로고    scopus 로고
    • Schreiber K, Stumpf C. Iscador in der postoperativen Therapie des Ovarialkarzinoms: Ergebnisse 24jähriger Therapie. Erfahrungsheilkunde. 1984;33(6):349-358.
    • Schreiber K, Stumpf C. Iscador in der postoperativen Therapie des Ovarialkarzinoms: Ergebnisse 24jähriger Therapie. Erfahrungsheilkunde. 1984;33(6):349-358.
  • 42
    • 33750416140 scopus 로고    scopus 로고
    • Klinische Studien zur Misteltherapie der Krebserkrankung - Eine Übersicht
    • Kienle GS, Kiene H. Klinische Studien zur Misteltherapie der Krebserkrankung - Eine Übersicht. Erfahrungsheilkunde. 2004;53:193-209.
    • (2004) Erfahrungsheilkunde , vol.53 , pp. 193-209
    • Kienle, G.S.1    Kiene, H.2
  • 43
    • 0001484704 scopus 로고
    • Klinische Studien zur Misteltherapie karzinomatöser Erkrangungen. Eine Übersicht
    • 347-353
    • Kiene H. Klinische Studien zur Misteltherapie karzinomatöser Erkrangungen. Eine Übersicht, therapeutikon. 1989;3(6):347-353.
    • (1989) therapeutikon , vol.3 , Issue.6
    • Kiene, H.1
  • 44
    • 0242309731 scopus 로고    scopus 로고
    • Adverse effects during therapy with mistletoe extracts
    • Bussing A, ed, Amsterdam: Harwood Academic Publishers;
    • Stein GM, Berg PA. Adverse effects during therapy with mistletoe extracts. In: Bussing A, ed. Mistletoe - The Genus Viscum. Amsterdam: Harwood Academic Publishers; 2000:195-208.
    • (2000) Mistletoe - The Genus Viscum , pp. 195-208
    • Stein, G.M.1    Berg, P.A.2
  • 45
    • 35948971903 scopus 로고    scopus 로고
    • Unerwünschte Wirkungen der Misteltherapie bei Tumorpatienten - Eine systematische Übersicht
    • Scheer R, Bauer R, Becker H, Fintelmann V, Kemper FH, Schilcher H, eds, Essen: KVC Verlag;
    • Saller R, Kramer S, Iten F, Melzer J. Unerwünschte Wirkungen der Misteltherapie bei Tumorpatienten - Eine systematische Übersicht. In: Scheer R, Bauer R, Becker H, Fintelmann V, Kemper FH, Schilcher H, eds. Fortschritte in der Misteltherapie: Aktueller Stand der Forschung und klinische Anwendung. Essen: KVC Verlag; 2005:367-403.
    • (2005) Fortschritte in der Misteltherapie: Aktueller Stand der Forschung und klinische Anwendung , pp. 367-403
    • Saller, R.1    Kramer, S.2    Iten, F.3    Melzer, J.4
  • 46
    • 35948954097 scopus 로고    scopus 로고
    • Saller R, Reichling J, Melzer J. Die Misteltherapie. Erwünschte und unerwünschte Wirkungen in der wissenschaftlichen Diskussion - Teil 1. PraxisMagazin. 2005;21(12/2004-1/2005):6-14.
    • Saller R, Reichling J, Melzer J. Die Misteltherapie. Erwünschte und unerwünschte Wirkungen in der wissenschaftlichen Diskussion - Teil 1. PraxisMagazin. 2005;21(12/2004-1/2005):6-14.
  • 47
    • 35948939094 scopus 로고    scopus 로고
    • Saller R, Reichling J, Melzer J. Die Misteltherapie. Erwünschte und unerwünschte Wirkungen in der wissenschaftlichenDiskussion-Teil 2. PraxisMagazin.2005;22(2/2005):6-17.
    • Saller R, Reichling J, Melzer J. Die Misteltherapie. Erwünschte und unerwünschte Wirkungen in der wissenschaftlichenDiskussion-Teil 2. PraxisMagazin.2005;22(2/2005):6-17.
  • 48
    • 4344630940 scopus 로고    scopus 로고
    • Bock PR, Friedel WE, Hanisch J, Karasmann M, Schneider B. Wirksamkeit und Sicherheit der komplementären Langzeitbehandlung mit einem standardisierten Extrakt aus Europäischer Mistel (Viscum album L.) zusätzlich zur konventionellen adjuvanten onkologischen Therapie bei primärem, nicht metastasiertem Mammakarzinom. Ergebnisse einer multizentrischen, komparativen, retrolektiven, epidemiologischen Kohortenstudie in Deutschland und der Schweiz. Arzneimittel-Forschung (Drug Research). 2004;54(8):456-466.
    • Bock PR, Friedel WE, Hanisch J, Karasmann M, Schneider B. Wirksamkeit und Sicherheit der komplementären Langzeitbehandlung mit einem standardisierten Extrakt aus Europäischer Mistel (Viscum album L.) zusätzlich zur konventionellen adjuvanten onkologischen Therapie bei primärem, nicht metastasiertem Mammakarzinom. Ergebnisse einer multizentrischen, komparativen, retrolektiven, epidemiologischen Kohortenstudie in Deutschland und der Schweiz. Arzneimittel-Forschung (Drug Research). 2004;54(8):456-466.
  • 49
    • 12944320296 scopus 로고    scopus 로고
    • Safety and efficacy of the long-term adjuvant treatment of primary intermediate- to high-risk malignant melanoma (UICC/AJCC stage II and III) with a standardized fermented European mistletoe (Viscum album L.) extract: Results from a multicenter, comparative, epidemiological cohort study in Germany and Switzerland
    • Augustin M, Bock PR, Hanisch J, Karasmann M, Schneider B. Safety and efficacy of the long-term adjuvant treatment of primary intermediate- to high-risk malignant melanoma (UICC/AJCC stage II and III) with a standardized fermented European mistletoe (Viscum album L.) extract: Results from a multicenter, comparative, epidemiological cohort study in Germany and Switzerland. Arzneimittel-Forschung (Drug Research). 2005;55(1):38-49.
    • (2005) Arzneimittel-Forschung (Drug Research) , vol.55 , Issue.1 , pp. 38-49
    • Augustin, M.1    Bock, P.R.2    Hanisch, J.3    Karasmann, M.4    Schneider, B.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.